Rapid “epiretinal membrane” development following intravitreal bevacizumab for Coats' disease

PURPOSE: To report a case of rapid “epiretinal membrane” (“ERM”) development following intravitreal bevacizumab for juvenile Coats' disease. OBSERVATIONS: A 7-year old boy was followed for four years with asymptomatic stage 2 Coats' disease in his left eye. At age 11, he developed symptoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Kam, Andrew W., Hui, Michelle, Cherepanoff, Svetlana, Fung, Adrian T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Case report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010952/
https://www.ncbi.nlm.nih.gov/pubmed/29942874
http://dx.doi.org/10.1016/j.ajoc.2018.06.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010952/
https://www.ncbi.nlm.nih.gov/pubmed/29942874
http://dx.doi.org/10.1016/j.ajoc.2018.06.002

Ejemplares similares